Low bone mineral density is a prognostic factor for elderly patients with HCC undergoing TACE: results from a multicenter study

Lukas Müller, Aline Mähringer-Kunz, Timo Alexander Auer, Uli Fehrenbach, Bernhard Gebauer, Johannes Haubold, Jens M. Theysohn, Moon Kim, Jens Kleesiek, Thierno D. Diallo, Michel Eisenblätter, Dominik Bettinger, Verena Steinle, Philipp Mayer, David Zopfs, Daniel Pinto Dos Santos, Roman Kloeckner
August, 2022
Cite DOI URL

Abstract

Low bone mineral density (BMD) was recently identified as a novel risk factor for patients with hepatocellular carcinoma (HCC). In this multicenter study, we aimed to validate the role of BMD as a prognostic factor for patients with HCC undergoing transarterial chemoembolization (TACE).

Type
Journal article
Publication
European Radiology
Bone mineral density Hepatocellular Carcinoma prognosis Transarterial Chemoembolization
Moon Kim
Moon Kim
Team Lead Medical Informatics
Jens Kleesiek
Jens Kleesiek
Professor of Translational Image-guided Oncology